In hypertrophic cardiomyopathy reduction of relative resting myocardial blood flow is related to late enhancement, T2-signal and LV wall thickness

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Hueper, Katja ^a,b   Zapf, Antonia ^b   Skrok, Jan ^a   Pinheiro, Aurelio ^a   Goldstein, Thomas A ^c   Zheng, Jie ^d   Zimmerman, Stefan L ^a   Kamel, Ihab R ^a   Abraham, Roselle ^a   Wacker, Frank ^a,b   Bluemke, David A ^e   Abraham, Theodore ^a   Vogel Claussen, Jens ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Stanford University   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; FEMALE; HEART EDEMA; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART MUSCLE RELAXATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; RADIOLOGICAL PARAMETERS; SCORING SYSTEM;

CARDIOMYOPATHY, HYPERTROPHIC; CORONARY VESSELS; FEMALE; GADOLINIUM; HUMANS; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW;

EID: 84864468168     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041974     Document Type: Article

References (39)

1. Maron BJ, ((2002)) Hypertrophic cardiomyopathy: a systematic review. JAMA 287:: 1308-1320.
2. Maron BJ, ((1997)) Hypertrophic cardiomyopathy. Lancet 350:: 127-133.
3. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, et al. ((1995)) Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 92:: 785-789.
4. Wigle ED, Rakowski H, Kimball BP, Williams WG, ((1995)) Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation 92:: 1680-1692.
5. Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, et al. ((2000)) Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 36:: 2212-2218.
6. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, et al. ((2000)) Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342:: 1778-1785.
7. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, et al. ((2003)) Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348:: 295-303.
8. Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, et al. ((2003)) Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41:: 1561-1567.
9. O'Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, et al. ((2010)) Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 56:: 867-874.
10. O'Gara PT, Bonow RO, Maron BJ, Damske BA, Van Lingen A, et al. ((1987)) Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography. Circulation 76:: 1214-1223.
11. Maron BJ, Wolfson JK, Epstein SE, Roberts WC, ((1986)) Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 8:: 545-557.
12. Romero-Farina G, Candell-Riera J, Galve E, Armadans L, Ramos F, et al. ((2004)) Do myocardial perfusion SPECT and radionuclide angiography studies in adult patients with hypertrophic cardiomyopathy have prognostic implications? J Nucl Cardiol 11:: 578-586.
13. Dilsizian V, Bonow RO, Epstein SE, Fananapazir L, ((1993)) Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 22:: 796-804.
14. von Dohlen TW, Prisant LM, Frank MJ, ((1989)) Significance of positive or negative thallium-201 scintigraphy in hypertrophic cardiomyopathy. Am J Cardiol 64:: 498-503.
15. Yamada M, Elliott PM, Kaski JC, Prasad K, Gane JN, et al. ((1998)) Dipyridamole stress thallium-201 perfusion abnormalities in patients with hypertrophic cardiomyopathy. Relationship to clinical presentation and outcome. Eur Heart J 19:: 500-507.
16. Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, et al. ((2003)) Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 349:: 1027-1035.
17. Knaapen P, van Dockum WG, Bondarenko O, Kok WE, Gotte MJ, et al. ((2005)) Delayed contrast enhancement and perfusable tissue index in hypertrophic cardiomyopathy: comparison between cardiac MRI and PET. J Nucl Med 46:: 923-929.
18. Abdel-Aty H, Cocker M, Strohm O, Filipchuk N, Friedrich MG, ((2008)) Abnormalities in T2-weighted cardiovascular magnetic resonance images of hypertrophic cardiomyopathy: regional distribution and relation to late gadolinium enhancement and severity of hypertrophy. J Magn Reson Imaging 28:: 242-245.
19. Abdel-Aty H, Zagrosek A, Schulz-Menger J, Taylor AJ, Messroghli D, et al. ((2004)) Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 109:: 2411-2416.
20. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, et al. ((2003)) American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42:: 1687-1713.
21. Fenchel M, Kramer U, Helber U, Stauder NI, Franow A, et al. ((2004)) Semiquantitative assessment of myocardial perfusion using magnetic resonance imaging: evaluation of appropriate thresholds and segmentation models. Invest Radiol 39:: 572-581.
22. Schreiber WG, Schmitt M, Kalden P, Mohrs OK, Kreitner KF, et al. ((2002)) Dynamic contrast-enhanced myocardial perfusion imaging using saturation-prepared TrueFISP. J Magn Reson Imaging 16:: 641-652.
23. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, et al. ((2002)) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging 18:: 539-542.
24. Christian TF, Bell SP, Whitesell L, Jerosch-Herold M, ((2009)) Accuracy of cardiac magnetic resonance of absolute myocardial blood flow with a high-field system: comparison with conventional field strength. JACC Cardiovasc Imaging 2:: 1103-1110.
25. Jerosch-Herold M, Wilke N, Stillman AE, ((1998)) Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained deconvolution. Med Phys 25:: 73-84.
26. Vogel-Claussen J, Skrok J, Shehata ML, Singh S, Sibley CT, et al. ((2011)) Right and left ventricular myocardial perfusion reserves correlate with right ventricular function and pulmonary hemodynamics in patients with pulmonary arterial hypertension. Radiology 258:: 119-127.
27. Goldstein TA, Jerosch-Herold M, Misselwitz B, Zhang H, Gropler RJ, et al. ((2008)) Fast mapping of myocardial blood flow with MR first-pass perfusion imaging. Magn Reson Med 59:: 1394-1400.
28. Goldstein TA, Zhang H, Misselwitz B, Gropler RG, Zheng J, ((2006)) Improvement of quantification of myocardial first-pass perfusion mapping: a temporal and spatial wavelet denoising method. Magn Reson Med 56:: 439-445.
29. Selvanayagam JB, Jerosch-Herold M, Porto I, Sheridan D, Cheng AS, et al. ((2005)) Resting myocardial blood flow is impaired in hibernating myocardium: a magnetic resonance study of quantitative perfusion assessment. Circulation 112:: 3289-3296.
30. Czernin J, Muller P, Chan S, Brunken RC, Porenta G, et al. ((1993)) Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 88:: 62-69.
31. Timmer SA, Germans T, Gotte MJ, Russel IK, Lubberink M, et al. ((2011)) Relation of coronary microvascular dysfunction in hypertrophic cardiomyopathy to contractile dysfunction independent from myocardial injury. Am J Cardiol 107:: 1522-1528.
32. Petersen SE, Jerosch-Herold M, Hudsmith LE, Robson MD, Francis JM, et al. ((2007)) Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 115:: 2418-2425.
33. Camici P, Chiriatti G, Lorenzoni R, Bellina RC, Gistri R, et al. ((1991)) Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 17:: 879-886.
34. Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, et al. ((2004)) The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 43:: 2260-2264.
35. Kim RJ, Judd RM, ((2003)) Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death? J Am Coll Cardiol 41:: 1568-1572.
36. Varnava AM, Elliott PM, Sharma S, McKenna WJ, Davies MJ, ((2000)) Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 84:: 476-482.
37. Iida H, Tamura Y, Kitamura K, Bloomfield PM, Eberl S, et al. ((2000)) Histochemical correlates of (15)O-water-perfusable tissue fraction in experimental canine studies of old myocardial infarction. J Nucl Med 41:: 1737-1745.
38. Kizilbash AM, Heinle SK, Grayburn PA, ((1998)) Spontaneous variability of left ventricular outflow tract gradient in hypertrophic obstructive cardiomyopathy. Circulation 97:: 461-466.
39. Geske JB, Sorajja P, Ommen SR, Nishimura RA, ((2009)) Left ventricular outflow tract gradient variability in hypertrophic cardiomyopathy. Clin Cardiol 32:: 397-402.